$18.54
-0.140 (-0.749%)
At Close: Jun 03, 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2024 Corporate Responsibility Report. The annual report demonstrates Baxter's commi
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
01:57pm, Wednesday, 11'th Jun 2025
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman
3 Top Goldman Sachs Dividend Stock Picks Have Up to 73% Upside Potential
07:18am, Sunday, 08'th Jun 2025
After a volatile stretch, yields in the Treasury bond market have stabilized. Concerns about the volatility in the bond and stock markets are leading investors to top-quality dividend stocks.
BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025
04:15pm, Tuesday, 27'th May 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 20
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
11:51am, Wednesday, 21'st May 2025
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
06:46am, Friday, 16'th May 2025
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
The 'Goldilocks' Case For Baxter International
10:16am, Thursday, 08'th May 2025
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health
Baxter Declares Quarterly Dividend
04:15pm, Tuesday, 06'th May 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
01:27pm, Thursday, 01'st May 2025
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Sh
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
12:50pm, Thursday, 01'st May 2025
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts.
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
11:36am, Thursday, 01'st May 2025
On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Thursday, 01'st May 2025
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Thursday, 01'st May 2025
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
Baxter tops quarterly estimates on strong demand for medical devices
09:13am, Thursday, 01'st May 2025
Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-moni
Baxter Reports First-Quarter 2025 Results
07:15am, Thursday, 01'st May 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of
Sign In
Buy BAX